Antihypertensive efficacy of zofenopril and hydrochlorothiazide combination on ambulatory blood pressure

Blood Pressure

Volumn 15, Issue SUPPL. 1, 2006, Pages 7-17

  Parati, Gianfranco ^a   Omboni, Stefano ^b   Malacco, Ettore ^c   Castiglioni, G ^d   Cereda, U ^d   Corradi, L ^d   Fogari, R ^d   Garavelli, G ^d   Malacco, E ^d   Pisani, A ^d   Villa, G ^d  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b Data Management Unit   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d NONE

Author keywords

Ambulatory blood pressure monitoring; Antihypertensive treatment; Combination treatment; Essential hypertension; Hydrochlorothiazide; Zofenopril

Indexed keywords

HYDROCHLOROTHIAZIDE; ZOFENOPRIL;

ADULT; ARTICLE; ASTHENIA; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG WITHDRAWAL; EPIGASTRIC PAIN; FEMALE; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTPATIENT CARE; PERIPHERAL EDEMA; POLYURIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

EID: 33644795556     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08038020500501975     Document Type: Article

References (35)

1. Hansson, L. and Zanchetti, A. and Carruthers, SG. and Dahlof, B. and Elmfeldt, D. and Julius, S. and (1998) for the HOT Study Group. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet, 351, pp. 1755 - 1762.
2. The Heart Outcome Prevention Evaluation Study Investigators. N Engl J Med [342].
3. PROGRESS Collaborative Study Group. Lancet [358].
4. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. JAMA [288].
5. Julius, S. and Kjeldsen, S. E. and Weber, M. and Brunner, H. R. and Ekman, S. and Hansson, L. and (2004) Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomised trial. Lancet, 363, pp. 2022 - 2031. VALUE trial group
6. Guidelines Subcommittee of the World Health Organization-International Society of Hypertension (WHO-ISH) Mild Hypertension Liaison Committee. (1999) 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens, 17, pp. 151 - 183.
7. Chobanian, A. V. and Bakris, G. L. and Black, H. R. and Cushman, W. C. and Green, L. A. and Izzo, J. L Jr. and (2003) and the National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VII). JAMA, 289, pp. 2560 - 2572.
8. Guidelines Committee. J Hypertens [21].
9. Waeber, B. (2003) Combination therapy with ACE inhibitors/angiotensin II receptor antagonists and diuretics in hypertension. Expert Rev Cardiovasc Ther, 1, pp. 43 - 50.
10. Sica, D. A. (2002) Rationale for fixed-dose combinations in the treatment of hypertension: The cycle repeats. Drugs, 62, pp. 443 - 462.
11. Borghi, C. and Ambrosioni, E. and Survival of Myocardial Infarction Long-term Evaluation-2 Working Party. (2003) Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: Results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study. Am Heart J, 145, pp. 80 - 87.
12. Borghi, C. and Bacchelli, S. and Esposti, D. D. and Bignamini, A. and Magnani, B. and Ambrosioni, E. (1999) Effects of the administration of an angiotensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation. Am J Hypertens, 12, pp. 665 - 672.
13. Borghi, C. and Bacchelli, S. and Esposti, D. D. and Ambrosioni, E. and SMILE Study. (2003) Effects of the early ACE inhibition in diabetic nonthrombolyzed patients with anterior acute myocardial infarction. Diabetes Care, 26, pp. 1862 - 1868.
14. Kelbaek, H. and Agner, E. and Wroblewski, H. and Vasehus Madsen, P. and Marving, J. (1993) Angiotensin converting enzyme inhibition at rest and during exercise in congestive heart failure. Eur Heart J, 14, pp. 692 - 695.
15. Binkley, P. F. and Haas, G. J. and Starling, R. C. and Nunziata, E. and Hatton, P. A. and Leier, C. V. and Cody, R. J. (1993) Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. J Am Coll Cardiol, 21, pp. 655 - 661.
16. Elijovich, F. and Laffer, C. L. and Schiffrin, E. L. (1997) The effects of atenolol and zofenopril on plasma atrial natriuretic peptide are due to their interactions with target organ damage of essential hypertensive patients. J Hum Hypertens, 11, pp. 313 - 319.
17. Lacourciere, Y. and Provencher, P. (1989) Comparative effects of zofenopril and hydrochlorothiazide on office and ambulatory blood pressures in mild to moderate essential hypertension. Br J Clin Pharmacol, 27, pp. 371 - 376.
18. Malacco, E. and Piazza, S. and Omboni, S. (2005) Zofenopril versus lisinopril in the treatment of essential hypertension in elderly patients. A randomised, double-blind, multicentre study. Clin Drug Invest, 25, pp. 175 - 182.
19. O'Brien, E. and Pickering, T. and Asmar, R. and Myers, M. and Parati, G. and Staessen, J. and Working Group on Blood Pressure Monitoring of the European Society of Hypertension. (2002) Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults. Blood Press Monit, 7, pp. 3 - 17.
20. Parati, G. and Bosi, S. and Castellano, M. and Cristofari, M. and Di Rienzo, M. and Germanò, G. and (1995) Guidelines for 24h non-invasive ambulatory blood pressure monitoring. Report from a working group of the Italian Society of Hypertension. High Blood Press, 4, pp. 168 - 174.
21. Rizzoni, D. and Castellano, M. and Muiesan, M. L. and Porteri, E. and Agabiti-Rosei, E. (1997) Beyond trough:pEak ratio: A new index of the smoothness of the antihypertensive effect of a drug. High Blood Press, 6, pp. 110 - 115.
22. Parati, G. and Omboni, S. and Rizzoni, D. and Agabiti-Rosei, E. and Mancia, G. (1998) The smoothness index: A new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens, 16, pp. 1685 - 1691.
23. Omboni, S. and Parati, G. and Mancia, G. (1998) The trough:pEak ratio and the smoothness index in the evaluation of control of 24h blood pressure by treatment in hypertension. Blood Press Monit, 3, pp. 201 - 204.
24. Rizzoni, D. and Muiesan, M. L. and Salvetti, M. and Castellano, M. and Bettoni, G. and Monteduro, C. and (2001) The smoothness index, but not the trough-to-peak ratio predicts changes in carotid artery wall thickness during antihypertensive treatment. J Hypertens, 19, pp. 703 - 711.
25. Mancia, G. and Parati, G. (2004) Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: A meta-analysis. J Hypertens, 22, pp. 435 - 445.
26. Ames, R. P. (1996) A comparison of blood lipid and blood pressure responses during the treatment of systemic hypertension with indapamide and with thiazides. Am J Cardiol, 77, pp. 12b - 16b.
27. Weidmann, P. and de Courten, M. and Ferrari, P. and Bohlen, L. (1993) Serum lipoproteins during treatment with antihypertensive drugs. J Cardiovasc Pharmacol, 22(Suppl 6), pp. S98 - S105.
28. Kannel, W. B. and Kannel, C. and Paffenbarger, R. S Jr. and Cupples, L. A. (1987) Heart rate and cardiovascular mortality: The Framingham Study. Am Heart J, 6, pp. 1489 - 1494.
29. Palatini, P. and Julius, S. (1997) Heart rate and the cardiovascular risk. J Hypertens, 15, pp. 3 - 17.
30. Schwieler, J. H. and Kahan, T. and Nussberger, J. and Hjemdahl, P. (1993) Converting enzyme inhibition modulates sympathetic neurotransmission in vivo via multiple mechanisms. Am J Physiol, 264, pp. E631 - 637.
31. Osterziel, K. J. and Dietz, R. (1996) Improvement of vagal tone by ACE inhibition: A mechanism of cardioprotection in patients with mild-to-moderate heart failure. J Cardiovasc Pharmacol, 27(Suppl 2), pp. S25 - S30.
32. Mancia, G. and Omboni, S. and Parati, G. (1997) Assessment of antihypertensive treatment by ambulatory blood pressure. J Hypertens, 15(Suppl), pp. S43 - S50.
33. Conway, J. and Coats, A. J. S. (1991) Ambulatory blood pressure monitoring in the design of antihypertensive drug trials. J Hypertens, 9(Suppl 8), pp. S57 - S58.
34. Trazzi, S. and Mutti, E. and Frattola, A. and Imholz, B. and Parati, G. and Mancia, G. (1991) Reproducibility of non-invasive and intra-arterial blood pressure monitoring: Implications for studies on antihypertensive treatment. J Hypertens, 9, pp. 115 - 119.
35. Mancia, G. and Omboni, S. and Parati, G. and Ravogli, A. and Villani, A. and Zanchetti, A. (1995) Lack of placebo effect on ambulatory blood pressure. Am J Hypertens, 8, pp. 311 - 315.